Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Distinguishing sudden infant death syndrome from child abuse fatalities.

BIBLIOGRAPHIC SOURCE(S)

GUIDELINE STATUS

This is the current release of the guideline.

All clinical reports from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

The following are important conclusions in the evaluation of sudden, unexplained infant deaths:

  • Accurate history taking by emergency responders and medical personnel at the time of death and immediate transmission of this historical information to the medical examiner or coroner
  • Prompt investigation of the scene (Centers for Disease Control and Prevention, 1996; Bass, Kravath, & Glass, 1986) at which the infant was found lifeless or unresponsive and careful interviews of household members by knowledgeable individuals with the legal authority and mandate to conduct such investigations
  • Appropriate consultations with available medical specialists (e.g., pediatrician, pediatric pathologist, pediatric radiologist, and/or pediatric neuropathologist) by medical examiners and coroners
  • Complete autopsy performed by a forensic pathologist within 24 hours of death, including examination of all major body cavities including cranial contents, microscopic examination of major organs, radiographic examination, and toxicological and metabolic screening
  • Collection of medical history through interviews of caregivers, interviews of key medical providers, and review of previous medical charts
  • Maintenance of an unbiased, nonaccusatory approach to parents during the death-review process
  • Consideration of intentional asphyxia in cases of unexpected infant death with a history of recurrent cyanosis, apnea, or apparent life-threatening events (ALTEs) witnessed only by a single caregiver
  • Use of accepted diagnostic categories on death certificates as soon as possible after review
  • Prompt imparting of information to parents when results indicate Sudden Infant Death Syndrome (SIDS) or accidental or medical causation of death
  • Review of collected data by locally based infant death-review teams (Granik, Durfee, & Wells, 1991) with participation of the medical examiner or coroner

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

REFERENCES SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of evidence supporting each recommendation is not specifically stated.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2001 Feb (revised 2006 Jul)

GUIDELINE DEVELOPER(S)

American Academy of Pediatrics - Medical Specialty Society

SOURCE(S) OF FUNDING

American Academy of Pediatrics

GUIDELINE COMMITTEE

Committee on Child Abuse and Neglect

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Committee on Child Abuse and Neglect, 2004-2005: Robert W. Block, MD, Chairperson; Roberta Ann Hibbard, MD; Carole Jenny, MD, MBA; Nancy D. Kellogg, MD; Betty S. Spivack, MD; John Stirling, Jr, MD; Kent P. Hymel, MD, Past Committee Member

Liaison Representatives: David L. Corwin, MD, American Academy of Child and Adolescent Psychiatry; Joanne Klevens, MD, MPH, Centers for Disease Control and Prevention

Staff: Tammy Piazza Hurley

National Association of Medical Examiners: Randy Hanzlick, MD; Michael Graham, MD; Tracey S. Corey, MD

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

ENDORSER(S)

National Association of Medical Examiners - Professional Association

GUIDELINE STATUS

This is the current release of the guideline.

All clinical reports from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.

GUIDELINE AVAILABILITY

Electronic copies: Available from the American Academy of Pediatrics (AAP) Policy Web site.

Print copies: Available from American Academy of Pediatrics, 141 Northwest Point Blvd., P.O. Box 927, Elk Grove Village, IL 60009-0927.

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on September 17, 2001. The information was verified by the guideline developer as of December 5, 2001. This summary was updated by ECRI on August 14, 2006. The updated information was verified by the guideline developer on September 1, 2006.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions. Please contact the Permissions Editor, American Academy of Pediatrics (AAP), 141 Northwest Point Blvd, Elk Grove Village, IL 60007.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo